Cargando…

Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses

The novel coronavirus SARS-CoV-2 is damaging the world’s social and economic fabrics seriously. Effective drugs are urgently needed to decrease the high mortality rate of COVID-19 patients. Unfortunately, effective antiviral drugs or vaccines are currently unavailable. Herein, we systematically eval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Guobing, Ruan, Shasha, Zhao, Xiaolu, Liu, Qi, Dou, Yali, Mao, Fengbiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Research Network of Computational and Structural Biotechnology 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719282/ https://www.ncbi.nlm.nih.gov/pubmed/33312453 http://dx.doi.org/10.1016/j.csbj.2020.11.056

Ejemplares similares

Genetic association and single-cell transcriptome analyses reveal distinct features connecting autoimmunity with cancers
por: Li, Shasha, et al.
Publicado: (2022)

Validation of transcriptome signature reversion for drug repurposing in oncology
por: Koudijs, Karel K M, et al.
Publicado: (2022)

Network bioinformatics analysis provides insight into drug repurposing for COVID-19
por: Li, Xu, et al.
Publicado: (2021)

Identification of Molecular Signatures and Candidate Drugs in Vascular Dementia by Bioinformatics Analyses
por: Shu, Jun, et al.
Publicado: (2022)

EpiDenovo: a platform for linking regulatory de novo mutations to developmental epigenetics and diseases
por: Mao, Fengbiao, et al.
Publicado: (2018)

Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses
por: You, Guo-Rung, et al.
Publicado: (2019)

Insights into bioinformatic approaches for repurposing compounds as anti-viral drugs
por: Zheng, Wenxiao, et al.
Publicado: (2021)

Molecularly Guided Drug Repurposing for Cholangiocarcinoma: An Integrative Bioinformatic Approach
por: Venkatraman, Simran, et al.
Publicado: (2022)

Editorial: Artificial Intelligence in Bioinformatics and Drug Repurposing: Methods and Applications
por: Zheng, Pan, et al.
Publicado: (2022)

Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach
por: O’Donovan, Sinead M., et al.
Publicado: (2021)

Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
por: Sakai, Norihiro, et al.
Publicado: (2023)

Transcriptome-Guided Drug Repurposing for Aggressive SCCs
por: Zauner, Roland, et al.
Publicado: (2022)

Pathway-Based Drug-Repurposing Schemes in Cancer: The Role of Translational Bioinformatics
por: Hernández-Lemus, Enrique, et al.
Publicado: (2021)

Multi-ancestry transcriptome-wide association analyses yield insights into tobacco use biology and drug repurposing
por: Chen, Fang, et al.
Publicado: (2023)

OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers
por: Wang, Tao, et al.
Publicado: (2020)

CircleBase: an integrated resource and analysis platform for human eccDNAs
por: Zhao, Xiaolu, et al.
Publicado: (2021)

Transcriptome signature analysis repurposes trifluoperazine for the treatment of fragile X syndrome in mouse model
por: Ding, Qi, et al.
Publicado: (2020)

Transcriptomic signature associated with carcinogenesis and aggressiveness of papillary thyroid carcinoma
por: Teng, Huajing, et al.
Publicado: (2018)

A Transcriptomics-Based Bioinformatics Approach for Identification and In Vitro Screening of FDA-Approved Drugs for Repurposing against Dengue Virus-2
por: Punekar, Madhura, et al.
Publicado: (2022)

Identification of Potential Repurposable Drugs in Alzheimer’s Disease Exploiting a Bioinformatics Analysis
por: Fiscon, Giulia, et al.
Publicado: (2022)

Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics
por: Liu, Dan-Yang, et al.
Publicado: (2021)

Drug repurposing in idiopathic pulmonary fibrosis filtered by a bioinformatics-derived composite score
por: Karatzas, E., et al.
Publicado: (2017)

Integration of genomic variants and bioinformatic-based approach to drive drug repurposing for multiple sclerosis
por: Afief, Arief Rahman, et al.
Publicado: (2022)

Genomic variants-driven drug repurposing for tuberculosis by utilizing the established bioinformatic-based approach
por: Irham, Lalu Muhammad, et al.
Publicado: (2022)

Repurposing Approved Drugs for Sarcopenia Based on Transcriptomics Data in Humans
por: Liang, Shuang, et al.
Publicado: (2023)

Enhancement of the IFN-β-induced host signature informs repurposed drugs for COVID-19
por: Huang, Chen-Tsung, et al.
Publicado: (2020)

Bioinformatic Analyses of the Ferroptosis-Related lncRNAs Signature for Ovarian Cancer
por: Zheng, Jianfeng, et al.
Publicado: (2022)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

COMPARE Analysis, a Bioinformatic Approach to Accelerate Drug Repurposing against Covid-19 and Other Emerging Epidemics
por: Naasani, Imad
Publicado: (2021)

Breaking the paradigm: Dr Insight empowers signature-free, enhanced drug repurposing
por: Chan, Jinyan, et al.
Publicado: (2019)

Drug repurposing based on the similarity gene expression signatures to explore for potential indications of quercetin: a case study of multiple sclerosis
por: Chen, Yulong, et al.
Publicado: (2023)

MEDB-87. Transcriptome-driven drug repurposing in group 3 medulloblastoma
por: Doss, David, et al.
Publicado: (2022)

MDB-40. TRANSCRIPTOME-BASED DRUG REPURPOSING IN GROUP 3 MEDULLOBLASTOMA
por: Doss, David, et al.
Publicado: (2023)

Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma
por: Saeed, Mohamed E. M., et al.
Publicado: (2020)

Identification and validation of a five-gene prognostic signature based on bioinformatics analyses in breast cancer
por: Du, Xin-jie, et al.
Publicado: (2023)

In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic Data
por: Das, Shaoli, et al.
Publicado: (2020)

Bioinformatic analysis identifies key transcriptome signatures in temporal lobe epilepsy
por: Chen, Qing‐Lan, et al.
Publicado: (2020)

Identification of an Immune-Related Prognostic Signature for Glioblastoma by Comprehensive Bioinformatics and Experimental Analyses
por: Ye, Shengda, et al.
Publicado: (2022)

Repurposing new drug candidates and identifying crucial molecules underlying PCOS Pathogenesis Based On Bioinformatics Analysis
por: Dehghan, Zeinab, et al.
Publicado: (2021)

Six-Gene Signature Associated with Immune Cells in the Progression of Atherosclerosis Discovered by Comprehensive Bioinformatics Analyses
por: Zhao, Bin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7ocdife8qfc0rrbub8r93s8f4e